<?xml version="1.0" encoding="UTF-8"?>
<TEI
    xmlns="http://www.tei-c.org/ns/1.0"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /opt/1.6.1.6.1.2/schemas/xsd/Grobid.xsd"
    xmlns:xlink="http://www.w3.org/1999/xlink">
    <teiHeader xml:lang="en">
        <encodingDesc>
            <appInfo>
                <application version="0.4.1" ident="GROBID" when="2018-03-26T09:51+0000">
                    <ref target="https://github.com/kermitt2/grobid">GROBID - A machine learning software for extracting information from scholarly documents</ref>
                </application>
            </appInfo>
        </encodingDesc>
        <fileDesc>
            <titleStmt>
                <title level="a" type="main">Protective effects of fisetin against 6-OHDA-induced apoptosis by activation of PI3K-Akt signaling in human neuroblastoma SH-SY5Y cells</title>
            </titleStmt>
            <publicationStmt>
                <publisher/>
                <availability status="unknown">
                    <licence/>
                </availability>
            </publicationStmt>
            <sourceDesc>
                <biblStruct>
                    <analytic>
                        <author>
                            <persName>
                                <forename type="first">Ryoko</forename>
                                <surname>Watanabe</surname>
                            </persName>
                            <affiliation key="aff1">
                                <orgName type="department">Laboratory of Pathobiochemistry</orgName>
                                <orgName type="institution">Osaka University of Pharmaceutical Sciences</orgName>
                                <address>
                                    <addrLine>4-20-1 Nasahara</addrLine>
                                    <postCode>569-1094</postCode>
                                    <settlement>Takatsuki</settlement>
                                    <region>Osaka</region>
                                    <country key="JP">Japan</country>
                                </address>
                            </affiliation>
                        </author>
                        <author>
                            <persName>
                                <forename type="first">Takumi</forename>
                                <surname>Kurose</surname>
                            </persName>
                            <affiliation key="aff1">
                                <orgName type="department">Laboratory of Pathobiochemistry</orgName>
                                <orgName type="institution">Osaka University of Pharmaceutical Sciences</orgName>
                                <address>
                                    <addrLine>4-20-1 Nasahara</addrLine>
                                    <postCode>569-1094</postCode>
                                    <settlement>Takatsuki</settlement>
                                    <region>Osaka</region>
                                    <country key="JP">Japan</country>
                                </address>
                            </affiliation>
                        </author>
                        <author>
                            <persName>
                                <forename type="first">Yuta</forename>
                                <surname>Morishige</surname>
                            </persName>
                            <affiliation key="aff2">
                                <orgName type="department">Laboratory of Biodefense and Regulation</orgName>
                                <orgName type="institution">Osaka University of Pharmaceutical Sciences</orgName>
                                <address>
                                    <addrLine>4-20-1 Nasahara</addrLine>
                                    <postCode>569-1094</postCode>
                                    <settlement>Takatsuki</settlement>
                                    <region>Osaka</region>
                                    <country key="JP">Japan</country>
                                </address>
                            </affiliation>
							<affiliation key="aff4">
                                <address>
									<orgName type="institution">Research Institute of Tuberculosis</orgName>
                                    <addrLine>3-1-24 Matsuyama, Kiyose</addrLine>
                                    <postCode>204-8533</postCode>
									<settlement>Tokyo</settlement>
                                    <country key="JP">Japan</country>
                                </address>
                            </affiliation>
                        </author>
                        <author role="corresp" sequence="1">
                            <persName>
                                <forename type="first">Ko</forename>
                                <surname>Fujimori</surname>
                            </persName>
                            <contact>
                                <email>fujimori@gly.oups.ac.jp</email>
                                <phone>+81-72-690-1215</phone>
                            </contact>
                            <affiliation key="aff1">
                                <orgName type="department">Laboratory of Pathobiochemistry</orgName>
                                <orgName type="institution">Osaka University of Pharmaceutical Sciences</orgName>
                                <address>
                                    <addrLine>4-20-1 Nasahara</addrLine>
                                    <postCode>569-1094</postCode>
                                    <settlement>Takatsuki</settlement>
                                    <region>Osaka</region>
                                    <country key="JP">Japan</country>
                                </address>
                            </affiliation>
							<affiliation key="aff3">
                                <orgName type="department">Laboratory of Pathobiochemistry</orgName>
                                <orgName type="institution">Osaka University of Pharmaceutical Sciences</orgName>
                                <address>
                                    <addrLine>4-20-1 Nasahara</addrLine>
                                    <postCode>569-1094</postCode>
									<settlement>Takatsuki</settlement>
                                    <region>Osaka</region>
                                    <country key="JP">Japan</country>
                                </address>
                            </affiliation>
                        </author>
                        
                        <title level="a" type="main">Protective effects of fisetin against 6-OHDA-induced apoptosis by activation of PI3K-Akt signaling in human neuroblastoma SH-SY5Y cells</title>
                    </analytic>
                    <monogr>
                        <imprint>
                            <date/>
                        </imprint>
                    </monogr>
                    <note>*To whom correspondence should be addressed; 1 Present address; Abbreviations PD, Parkinson&apos;s disease; ROS, reactive oxygen species; 6-OHDA, 6-hydroxydopamine ; fisetin, 3,3&apos;,4&apos;,7-tetrahydroxyflavone; ERK, extracellular signal-regulated kinase; HRP, horseradish peroxidase; DCDFA, 2&apos;,7&apos;-Dichlorofluorescein diacetate; DMEM, Dulbecco&apos;s modified Eagle&apos;s medium; LDH, lactate dehydrogenase; qPCR, quantitative PCR; HO-1, hemeoxygenase-1; NQO1, NAD(P)H dehydrogenase quinone 1; NRF2, NF-E2-related factor 2; GCLM, ?-glutamate-cysteine ligase modifier; PI3K, phosphoinositide 3-kinase; Akti, Akt inhibitor</note>
                </biblStruct>
            </sourceDesc>
        </fileDesc>
        <profileDesc>
            <abstract/>
        </profileDesc>
    </teiHeader>
    <text xml:lang="en"></text>
</TEI>